These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2967272

  • 21. Modeling study of the structure of the macromolecular antitumor antibiotic neocarzinostatin. Origin of the stabilization of the chromophore.
    Ishiguro M, Imajo S, Hirama M.
    J Med Chem; 1991 Aug; 34(8):2366-73. PubMed ID: 1831507
    [Abstract] [Full Text] [Related]

  • 22. Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore.
    Tanaka T, Fukuda-Ishisaka S, Hirama M, Otani T.
    J Mol Biol; 2001 May 25; 309(1):267-83. PubMed ID: 11491295
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sequence-specific, strand-selective, and directional binding of neocarzinostatin chromophore to oligodeoxyribonucleotides.
    Lee SH, Goldberg IH.
    Biochemistry; 1989 Feb 07; 28(3):1019-26. PubMed ID: 2523731
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic.
    Maeda H, Takeshita J, Kanamaru R.
    Int J Pept Protein Res; 1979 Aug 07; 14(2):81-7. PubMed ID: 158571
    [Abstract] [Full Text] [Related]

  • 33. Development of an enantioselective synthetic route to neocarzinostatin chromophore and its use for multiple radioisotopic incorporation.
    Myers AG, Glatthar R, Hammond M, Harrington PM, Kuo EY, Liang J, Schaus SE, Wu Y, Xiang JN.
    J Am Chem Soc; 2002 May 15; 124(19):5380-401. PubMed ID: 11996579
    [Abstract] [Full Text] [Related]

  • 34. [Mechanisms of actions of neocarzinostatin (NCS) and NCS-associated nonprotein chromophore (author's transl)].
    Ohtsuki K, Ishida N.
    Tanpakushitsu Kakusan Koso; 1981 Jun 15; 26(7):937-49. PubMed ID: 6457319
    [No Abstract] [Full Text] [Related]

  • 35. DNA cleavage characteristics of non-protein enediyne antibiotic N1999A2.
    Miyagawa N, Sasaki D, Matsuoka M, Imanishi M, Ando T, Sugiura Y.
    Biochem Biophys Res Commun; 2003 Jun 20; 306(1):87-92. PubMed ID: 12788070
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Spontaneous deamidation of a protein antibiotic, neocarzinostatin, at weakly acidic pH. Conversion to a homologous inactive preneocarzinostatin due to change of asparagine 83 to aspartic acid 83 accompanied by conformational and biological alterations.
    Maeda H, Kuromizu K.
    J Biochem; 1977 Jan 20; 81(1):25-35. PubMed ID: 14934
    [Abstract] [Full Text] [Related]

  • 39. NMR studies of the post-activated neocarzinostatin chromophore-DNA complex. Conformational changes induced in drug and DNA.
    Gao X, Stassinopoulos A, Gu J, Goldberg IH.
    Bioorg Med Chem; 1995 Jun 20; 3(6):795-809. PubMed ID: 7582957
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.